Efficacy and safety of acupuncture at Different depths of Qugu Acupoint in the treatment of benign prostatic hyperplasia: a randomized controlled trial

Phase 1

• Conditions: Benign Prostatic Hyperplasia

• Registration Number: ITMCTR2200005751
• Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

(1)It meets the diagnostic criteria of BPH and has been clearly diagnosed by a specialist;
(2)The age ranges from 50 to 80;
(3)Voluntary subjects who sign informed consent voluntarily.

Exclusion Criteria

(1) Unable to communicate unobstructed;
(2) Associated with urethritis, acute prostatitis, urinary calculi and other diseases;
(3) Complicated with neurogenic bladder, bladder neck fibrosis, urethral stricture and other diseases;
(4) Patients with neurological diseases or diabetes that affect urination function;
(5) Hyperplasia of prostate complicated with malignant wasting diseases such as prostate cancer and tuberculosis;
(6) Patients with serious diseases such as liver and kidney insufficiency and other heart and lung diseases and blood diseases;
(7) Patients taking anticoagulants for a long time and patients with severe anemia;
(8) Patients with upper urinary tract obstruction and hydronephrosis and impaired renal function found by B-ultrasound;
(9) Have been using drugs that may affect bladder function or are receiving BPH drugs;
(10) B ultrasound or CT found excessive prostatic hyperplasia, protruding too much bladder, affecting acupuncture operators;
(11) B ultrasound or CT found that residual urine in the bladder was more than 100ml or too much, which affected the acupuncture operator.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
International Prostate Symptom Score,IPSS;

Secondary Outcome Measures

Name	Time	Method
Quality of life,QoL;